发明授权
US08022084B2 Polymorphic forms of a GABAA agonist 有权
多形态的GABAA激动剂

Polymorphic forms of a GABAA agonist
摘要:
The present invention is directed to novel polymorphic forms of the compound 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrate (gaboxadol monohydrate). The invention is further concerned with pharmaceutical compositions containing the polymorphic forms as an active ingredient, methods for treatment of disorders susceptible to amelioration by GABAA receptor agonism with the polymorphic forms, and processes for the preparation of the polymorphic forms.
公开/授权文献
信息查询
0/0